Annals of Cancer Research and Therapy
Online ISSN : 1880-5469
Print ISSN : 1344-6835
ISSN-L : 1344-6835
Transumbilical Single-Port Laparoscopic Surgery for Colorectal Cancers: Experience of 258 Consecutive Cases with Rational Manipulation of Instrument for Safety and Benefit
Sho HirabayashiKenji HibiYoshihiro HottaRyohei FukumotoTakuya WatanabeJunichi SakamotoYasuhiro Kodera
著者情報
ジャーナル フリー

2016 年 24 巻 1 号 p. 7-11

詳細
抄録
Background: Single port laparoscopic surgery has been rapidly developing worldwide, with the potential for replacing conventional laparoscopic surgery.
Objective: Identification and evaluation of the safety, benefits and disadvantages of single port laparoscopic procedures through presentation of our experience.
Design: Retrospective review of surgical procedures and outcomes for two-hundred-fifty-eight consecutive cases of single port laparoscopic surgery for colorectal cancers, between September 2009 and March 2015.
Main Outcomes: Descriptive analysis of patients’ background characteristics (age, sex and cancer location), operative details (type, duration, intra-operative bleeding volume, intra-operative complication, conversion to open surgery), and postoperative follow-up (complications within 30 days).
Results: Cases included ileocaecal resection (n=36), right hemicolectomy (n=54), transverse colectomy (n=21), left hemicolectomy (n=25), sigmoidectomy (n=33), high anterior resection (n=68), low anterior resection (n=24), and abdominoperineal resection (n=1). Patient group included 137 men, 121 women, with a median age of 71 years (range, 26-94). Operative details included a median duration of 234.5min (range, 90-541) and a median blood loss was 70ml (range, 0-2560). The median follow-up period was 253 days (range, 13-703), with 21 reported complications in 17 patients.
Conclusions: Single-port transumbilical laparoscopic surgery is feasible and safe provided that the surgery is performed by experienced surgeons, compared to multiport laparoscopic procedures for colorectal cancers.
著者関連情報
© 2016 by The Japanese Society of Strategies for Cancer Research and Therapy
前の記事 次の記事
feedback
Top